Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
The pathogenetic significance of deregulated signal transduction pathways in Hodgkin's disease: the NF-kappaB-AP-1 networkC ScheidereitProceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virusC Scheidereit, M BeatoImmunobiology|January 27, 1998
Regulation of NF-kappa B activity by I kappa B alpha and I kappa B beta stabilityD Krappmann, C ScheidereitThe EMBO Journal|October 3, 1994
Activation of NF-kappa B in vivo is regulated by multiple phosphorylationsM Naumann, C ScheidereitThe Journal of Biological Chemistry|August 5, 1994
Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy chain and kappa light chain promotersS Franke, G Scholz, C ScheidereitCell|December 4, 1987
Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitroC Scheidereit, A Heguy, R G RoederCurrent Opinion in Immunology|February 19, 2000
NF-kappaB and the innate immune responseE N Hatada, D Krappmann, C ScheidereitNature|August 13, 1992
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa BF G Wulczyn, M Naumann, C ScheidereitThe EMBO Journal|December 2, 1996
Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivoD Krappmann, F G Wulczyn, C ScheidereitThe EMBO Journal|July 1, 1993
Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3E N Hatada, M Naumann, C ScheidereitPageof 6